NCT05351021View on ClinicalTrials.gov

Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

October 30, 2022

Study Completion Date

October 30, 2022

Conditions
Peripheral NeuropathyBreast Cancer
Interventions
DRUG

Metformin

cidophage 850 gm twice daily

DRUG

Placebo

placebo twice daily for treatment period

Trial Locations (1)

35516

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER